文献速递神经免疫

WNT9B基因变异增加多发性硬化复发风险

Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2021-03-24

该研究通过全基因组关联分析发现,WNT9B基因内的低频变异rs11871306与多发性硬化复发风险显著相关,并在复制队列中得到验证。通路分析提示维生素D反应通路与复发风险相关,而MS遗传风险评分与复发风险无关。

要点

  • WNT9B变异rs11871306与MS复发风险增高相关(HR=2.15)。
  • 维生素D反应通路与MS复发风险相关。
  • MS遗传风险评分与复发风险无关。

核心结论

  • WNT9B基因变异rs11871306与多发性硬化复发风险增加相关。
  • Wnt信号和维生素D通路可能调节MS疾病活动性。

研究设计与样本

  • 全基因组关联研究(GWAS),发现队列结合复制队列。
  • 合并队列共纳入991例患者,捕获2231次免疫调节治疗前复发。
  • 采用Cox比例风险模型进行生存分析。

主要发现

  • rs11871306达到全基因组显著性并在复制队列中验证(meta分析HR=2.15,95%CI=1.70-2.78,p=2.07×10^-10)。
  • 通路分析显示「对维生素D的反应」通路与复发风险相关(p=4.33×10^-6)。
  • MS遗传风险评分与复发风险无关联。

关键数值与推荐

  • rs11871306预测复发风险的meta分析HR=2.15(95%CI 1.70-2.78,p=2.07×10^-10)。
  • 「对维生素D的反应」通路与复发风险关联p=4.33×10^-6。

临床怎么用

  • WNT9B变异和维生素D通路可能作为MS疾病活动性的潜在调节因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many multiple sclerosis (MS) genetic susceptibility variants have been identified, but understanding disease heterogeneity remains a key challenge. Relapses are a core feature of MS and a common primary outcome of clinical trials, with prevention of relapses benefiting patients immediately and potentially limiting long-term disability accrual. We aim to identify genetic variation associated with relapse hazard in MS by analyzing the largest study population to date. METHODS: We performed a genomewide association study (GWAS) in a discovery cohort and investigated the genomewide significant variants in a replication cohort. Combining both cohorts, we captured a total of 2,231 relapses occurring before the start of any immunomodulatory treatment in 991 patients. For assessing time to relapse, we applied a survival analysis utilizing Cox proportional hazards models. We also investigated the association between MS genetic risk scores and relapse hazard and performed a gene ontology pathway analysis. RESULTS: The low-frequency genetic variant rs11871306 within WNT9B reached genomewide significance in predicting relapse hazard and replicated (meta-analysis hazard ratio (HR) = 2.15, 95% confidence interval (CI) = 1.70-2.78, p = 2.07 × 10-10 ). A pathway analysis identified an association of the pathway "response to vitamin D" with relapse hazard (p = 4.33 × 10-6 ). The MS genetic risk scores, however, were not associated with relapse hazard. INTERPRETATION: Genetic factors underlying disease heterogeneity differ from variants associated with MS susceptibility. Our findings imply that genetic variation within the Wnt signaling and vitamin D pathways contributes to differences in relapse occurrence. The present study highlights these cross-talking pathways as potential modulators of MS disease activity. ANN NEUROL 2021;89:884-894.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Vandebergh M, Andlauer TFM, Zhou Y, et al. Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis. Ann Neurol. 2021. PMID: 33704824. doi:10.1002/ana.26061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。